Qube Research & Technologies (QRT)
AVBP icon

Qube Research & Technologies (QRT)’s ArriVent BioPharma AVBP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.62M Buy
+70,317
New +$1.59M ﹤0.01% 2275
2024
Q4 		– Sell
-11,354
Closed -$267K – 3873
2024
Q3 		$267K Buy
+11,354
New +$258K ﹤0.01% 2470

Other funds holding AVBP

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Qube Research & Technologies (QRT)'s AVBP Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in ArriVent BioPharma (AVBP) in Q1 2026: 70,317 shares worth $1.62M. The stake represents ﹤0.01% of the portfolio and ranks #2275 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in AVBP as recently as Q3 2024.

Qube Research & Technologies (QRT) first reported a position in AVBP in Q3 2024 and has held it in 2 quarters since. 139 funds tracked by Wall St. Rank hold AVBP as of Q1 2026.

  • Qube Research & Technologies (QRT) held 70,317 shares of ArriVent BioPharma worth $1.62M as of Q1 2026.
  • ArriVent BioPharma was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • ArriVent BioPharma made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2275 holding.
  • Qube Research & Technologies (QRT) first reported a position in ArriVent BioPharma in Q3 2024 and has held it in 2 quarters since.
  • 139 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.